A new computational model can predict antibody structures more accurately
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
Using this model, researchers may be able to identify antibody drugs that can target a variety of infectious diseases.
Junior Katie Spivakovsky describes her path through New Engineering Education Transformation to biomedical research and beyond.
Most antibiotics target metabolically active bacteria, but with artificial intelligence, researchers can efficiently screen compounds that are lethal to dormant microbes.
These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.
A one-week summer program aims to foster a deeper understanding of machine-learning approaches in health among curious young minds.
This AI system only needs a small amount of data to predict molecular properties, which could speed up drug discovery and material development.
By applying a language model to protein-drug interactions, researchers can quickly screen large libraries of potential drug compounds.
The machine-learning algorithm identified a compound that kills Acinetobacter baumannii, a bacterium that lurks in many hospital settings.
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.